MILNER THERAPEUTICS SYMPOSIUM 2021


Tuesday 22nd June, Online

Milner Therapeutics Symposium 2021

Symposium Overview

Thank you for attending the 2021 Milner Therapeutics Symposium.
If you have questions relating to this event, or if you’d like to join our email list to receive information
about future events, please email events@milner.cam.ac.uk
.

This one-day online event was an opportunity for scientists from academia and industry to discuss their latest research and its potential to be applied in pharma and biotech towards new treatments.

PROGRAMME » 

Themes

Oncology   ·   CNS therapeutics   ·   Microbiome   ·   Emerging technologies   ·   Disease-relevant models in target discovery

Speakers

David Liu (Harvard) · Jeff Settleman (Pfizer) · Charles Swanton (The Francis Crick Institute and Achilles Therapeutics) · Nevan Krogan (UCSF) · Fiona Menzies (Eli Lilly and Company) · Virginia Pedicord (Cambridge Institute of Therapeutic Immunology and Infectious Disease) · Kostas Tzelepis (Milner Therapeutics Institute) · Marcel Gehrung (Cyted) · Joo-Hyeon Lee (Wellcome MRC Cambridge Stem Cell Institute)

You can find out more about our speakers further down this page.

Speakers & Sessions

 

Jenny Hirst

Charles Swanton

The Francis Crick Institute and Achilles Therapeutics

Mo Zhao

Fiona Menzies

 Eli Lilly and Company

Mo Zhao

David Liu

Harvard

Jenny Hirst

Kostas Tzelepis

 Milner Therapeutics Institute

Timothy Jenkins / Veterinary Medicine

Virginia Pedicord

 Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID)

Timothy Jenkins / Veterinary Medicine

Jeff Settleman

 Pfizer

Mo Zhao

Joo-Hyeon Lee

Wellcome MRC Cambridge Stem Cell Institute

Jenny Hirst

Nevan Krogan

University of California San Francisco

Panel Session: The Cambridge cluster: now and the future

 

Session 1: Cambridge and business … How can we work together?

Tony Kouzarides

Tony Kouzarides

Director, Milner Therapeutics Institute

Mo Zhao

Ian Tomlinson

Chair, Apollo Therapeutics and Start Codon

Jenny Hirst

Alan Hirzel

CEO, Abcam

Jenny Hirst

Derek Jones

Director, Babraham Research Campus

Mo Zhao

Jason Mellad

CEO, Start Codon

Susan Galbraith

Susan Galbraith

Senior Vice President and Head of Research and Early Development, Oncology R&D
AstraZeneca

Session 2: Cambridge and business… how can we deliver?

 

Tony Kouzarides

Tony Kouzarides

Director, Milner Therapeutics Institute

Mo Zhao

Ian Tomlinson

Chair, Apollo Therapeutics and Start Codon

Tony Kouzarides

Harriet Fear

Director, Cambridge&

Jenny Hirst

Mark Welland

Director, Maxwell Centre

Kathryn Chapman

Kathryn Chapman

Deputy Director, Milner Therapeutics Institute

Mo Zhao

Andy Neely

Pro-Vice-Chancellor for Enterprise and Business Relations
University of Cambridge

Pin It on Pinterest